Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision ATG With or Without Verapamil in Recent-Onset Type 1 Diabetes
NCT06455319Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Nov 2025
- Primary completion
- Nov 2028
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in type 1 diabetes mellitus (T1D), sponsored by University of Florida. Started Nov 2025; status: recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06455319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06455319.